Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Cyclosporine therapeutic drug monitoring in nephrotic syndrome: which time point to use for a generic product?
- In: Hospital Pharmacy Posters
- At: Hyderabad (India) (2011)
- Type: Poster
- Poster code: HPS-P-14
- By: DU, Xiaoli (Peking Union Medical College Hospital, Beijing, China)
- Co-author(s): Wang, Haiyun (Peking Union Medical College Hospital, Beijing, China)
Fu, Qiang (Peking Union Medical College Hospital, Beijing, China)
Chen, Limeng (Peking Union Medical College Hospital, Beijing, China)
Li, Xuemei (Peking Union Medical College Hospital, Beijing, China)
Zhu, Zhu (Peking Union Medical College Hospital, Beijing, China) - Abstract:
Background: C2 monitoring has been accepted for cyclosporine (CsA) TDM in organ transplantation for about 10 years. However, there is limited information on nephrotic syndrome (NS), although CsA is widely used in its treatment. Another issue is whether C2 remains the best choice for generic products. The aim of this study is to investigate the..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023